Recombinant chimeric monoclonal antibody to SARS-CoV-2 Spike Protein RBD for use as a research grade Rimteravimab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Rimteravimab Biosimilar - Anti-SARS-CoV-2 Spike Protein RBD Antibody - BSA and Azide free (A339186)
Dose-response for Rimteravimab Biosimilar - Anti-SARS-CoV-2 Spike Protein RBD Antibody - BSA and Azide free (A339186).
Publishing research using Rimteravimab Biosimilar - Anti-SARS-CoV-2 Spike Protein RBD Antibody - BSA and Azide free (A339186)? Please let us know so that we can list the citation on this page.